Overview

Plaque Psoriasis Study in Pediatric Subjects

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Calcitriol